BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia. (Record no. 24292214)

MARC details
000 -LEADER
fixed length control field 02423 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517000620.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201503s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1558-8238
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1172/JCI76539
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Yaktapour, Niuscha
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150302
245 00 - TITLE STATEMENT
Title BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Journal of clinical investigation
Date of publication, distribution, etc. Nov 2014
300 ## - PHYSICAL DESCRIPTION
Extent 5074-84 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Proliferation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Survival
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Extracellular Signal-Regulated MAP Kinases
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intracellular Signaling Peptides and Proteins
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Lymphocytic, Chronic, B-Cell
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MAP Kinase Signaling System
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation, Missense
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphorylation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Processing, Post-Translational
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins B-raf
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Radionuclide Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Syk Kinase
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vemurafenib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meiss, Frank
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mastroianni, Justin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zenz, Thorsten
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Andrlova, Hana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mathew, Nimitha R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Claus, Rainer
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hutter, Barbara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fröhling, Stefan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brors, Benedikt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pfeifer, Dietmar
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pantic, Milena
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bartsch, Ingrid
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spehl, Timo S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meyer, Philipp T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duyster, Justus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zirlik, Katja
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brummer, Tilman
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zeiser, Robert
773 0# - HOST ITEM ENTRY
Title The Journal of clinical investigation
Related parts vol. 124
-- no. 11
-- p. 5074-84
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1172/JCI76539">https://doi.org/10.1172/JCI76539</a>
Public note Available from publisher's website

No items available.